Bellecapital’s PDL BioPharma, Inc. PDLI Stock Holding History

Bellecapital’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-108,025	Closed	-$267K	–	204
2020 Q4	$267K	Hold	108,025	–	–	0.09%	159
2020 Q3	$315K	Buy	+108,025	New	+$345K	0.14%	118

Other funds holding PDLI

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

Bellecapital's PDLI Position: Q1 2021 in Review

Bellecapital sold out of PDL BioPharma, Inc. (PDLI) in Q1 2021, closing a stake of 108,025 shares — an estimated $267K sold.

Bellecapital first reported a position in PDLI in Q3 2020 and held it in 2 quarters. The position peaked at $315K in Q3 2020. 11 funds tracked by Wall St. Rank hold PDLI as of Q1 2021.

Bellecapital reported no remaining PDL BioPharma, Inc. position as of Q1 2021 after selling out during the quarter.
Bellecapital sold 108,025 PDL BioPharma, Inc. shares in Q1 2021, an estimated $267K.
Bellecapital first reported a position in PDL BioPharma, Inc. in Q3 2020 and held it in 2 quarters.
Bellecapital's PDL BioPharma, Inc. position peaked at $315K in Q3 2020.
11 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2021.

Based on Bellecapital's 13F filing for Q1 2021, filed 13 Apr 2021.